Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Kornek

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Pediatric Neurology|March 26, 2023
Humoral Immune Response Following SARS-CoV-2 mRNA Vaccination and Infection in Pediatric-Onset Multiple SclerosisMarkus Breu, Christian Lechner, Lisa Schneider, et al.
Scientific Reports|October 21, 2024
The presence of oligoclonal bands predicts conversion to multiple sclerosis in isolated myelitisTobias Monschein, Markus Ponleitner, Gabriel Bsteh, et al.
Journal of Neuropathology and Experimental Neurology|January 17, 2003
Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseasesFahmy Aboul-Enein, Helmut Rauschka, Barbara Kornek, et al.
Children (Basel, Switzerland)|November 27, 2025
Complications of Therapeutic Plasma Exchange in Pediatric Neuroimmune DisordersKathrin Eichinger, Markus Breu, Marleen Renken, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 25, 2012
Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndromeBarbara Kornek, Beate Schmitl, Karl Vass, et al.
Digital Health|November 10, 2022
Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trialPatrick Altmann, Markus Ponleitner, Tobias Monschein, et al.
Annals of Clinical and Translational Neurology|May 8, 2024
Alemtuzumab treatment for multiple sclerosis in Austria: An observational long-term outcome studyTobias Moser, Fabian Foettinger, Wolfgang Hitzl, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2003
New loci regulating rat myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitisKristina Becanovic, Erik Wallstrom, Barbara Kornek, et al.
Frontiers in Neurology|July 22, 2022
Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple SclerosisNik Krajnc, Gabriel Bsteh, Gregor Kasprian, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2022
Association of paramagnetic rim lesions and retinal layer thickness in patients with multiple sclerosisNik Krajnc, Assunta Dal-Bianco, Fritz Leutmezer, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Pediatric Neurology|March 26, 2023
Humoral Immune Response Following SARS-CoV-2 mRNA Vaccination and Infection in Pediatric-Onset Multiple SclerosisMarkus Breu, Christian Lechner, Lisa Schneider, et al.
Scientific Reports|October 21, 2024
The presence of oligoclonal bands predicts conversion to multiple sclerosis in isolated myelitisTobias Monschein, Markus Ponleitner, Gabriel Bsteh, et al.
Journal of Neuropathology and Experimental Neurology|January 17, 2003
Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseasesFahmy Aboul-Enein, Helmut Rauschka, Barbara Kornek, et al.
Children (Basel, Switzerland)|November 27, 2025
Complications of Therapeutic Plasma Exchange in Pediatric Neuroimmune DisordersKathrin Eichinger, Markus Breu, Marleen Renken, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 25, 2012
Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndromeBarbara Kornek, Beate Schmitl, Karl Vass, et al.
Digital Health|November 10, 2022
Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trialPatrick Altmann, Markus Ponleitner, Tobias Monschein, et al.
Annals of Clinical and Translational Neurology|May 8, 2024
Alemtuzumab treatment for multiple sclerosis in Austria: An observational long-term outcome studyTobias Moser, Fabian Foettinger, Wolfgang Hitzl, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2003
New loci regulating rat myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitisKristina Becanovic, Erik Wallstrom, Barbara Kornek, et al.
Frontiers in Neurology|July 22, 2022
Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple SclerosisNik Krajnc, Gabriel Bsteh, Gregor Kasprian, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2022
Association of paramagnetic rim lesions and retinal layer thickness in patients with multiple sclerosisNik Krajnc, Assunta Dal-Bianco, Fritz Leutmezer, et al.
Pageof 7